poisar

Stock

Accuray Incorporated ARAY

$0.23-3.49%

Overview

ARAY market data

Price History

ARAY price chart

Valuation & Profitability

no valuation data
No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for ARAY. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

5 captured
Why Q32 Bio Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 13, 2026, 8:39 AM
Accuray shares are trading higher after the company announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's Stellar adaptive radiation therapy platform.Benzinga · May 15, 2026, 9:00 PM
Accuray And The University of Wisconsin School of Medicine and Public Health Announce A New 10-Year Strategic Collaboration To Advance Personalized Cancer Treatments Using Accuray's Stellar Adaptive Radiation Therapy PlatformBenzinga · May 15, 2026, 8:24 PM
Jefferies Downgrades Accuray to Hold, Lowers Price Target to $0.35Benzinga · May 12, 2026, 9:35 PM
8-K filing — ACCURAY INC (ARAY)SEC EDGAR · May 6, 2026, 8:07 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock